Daniel Nadler

Daniel J. Nadler
Born1984[1]
Toronto, Ontario, Canada
Alma materHarvard University
Occupations
  • entrepreneur
  • poet

Daniel Joseph Nadler is a Canadian-born technology entrepreneur, artist, and poet.[2][3][4] He is the founder of OpenEvidence, a Sequoia Capital-backed medical artificial intelligence company used by over a quarter of doctors in the United States.[5] In 2025, OpenEvidence was valued at $1 billion by Sequoia.[6] In 2025 Nadler was named to the TIME100 list of the 100 Most Influential People in global health.[7]

He is also the founder and CEO of Kensho, a company applying machine learning to large financial data sets, which he founded in 2013 and was sold in 2018 to S&P Global for $550 million.

Early life and education

Daniel Nadler was born in Toronto, Ontario. His parents are from Poland and Romania. His father is an engineer and Nadler credits him for teaching "real math".[1] Nadler studied mathematics and classics at Harvard University, poetry with Jorie Graham. He was a visiting scholar at the Federal Reserve. In 2016 Nadler received a Ph.D. with a doctoral thesis on the pricing mechanisms of credit derivatives, involving new econometric and statistical approaches to modeling low probability, high impact events.[1]

Career

Kensho Technologies

In 2013, while still a Ph.D. student, Nadler co-founded Kensho Technologies, an artificial intelligence company that developed machine learning systems with Peter Kruskall. The software allows a user to perform financial analysis like a google search engine with a mission to "democratize quantitative analysis". Nadler leased it to Wall Street asset managers, in an analogy to Bloomberg and Reuters business model.[1] Nadler considers "Artificial intelligence [is] a misnomer. It's accelerated intelligence".[8] In 2017, at the World Economic Forum Kensho was named "one of the most innovative and impactful technology companies in the world".[9] In 2018 Kensho was acquired by S&P Global for $550 million and became, according to Forbes, the most valuable artificial intelligence company of the 2010s.[8]

OpenEvidence

In 2021 Nadler founded OpenEvidence,[10] an artificial intelligence company whose medical search engine is used by doctors for clinical decision support.[5] In 2025, Sequoia Capital, which is one of its main financial supporters, valued OpenEvidence at $1 billion.[6][5] As of December 2024, OpenEvidence was used by over a quarter of doctors in the United States.[11][5] In 2025 Nadler was named to the TIME100 list of the 100 Most Influential People in global health.[7]

Poetry

At Harvard University Nadler studied with Pulitzer Prize winning poet Jorie Graham while completing his Ph.D. in statistical and mathematical fields.[1] Nadler's debut collection of poetry, Lacunae: 100 Imagined Ancient Love Poems, was published by Farrar, Straus and Giroux in 2016 and was named a Best Book of the Year by NPR.[12][13] In 2018 Nadler was elected to the board of directors of the Academy of American Poets, becoming the youngest person ever to be elected to the Academy's Board in its 85-year history.[14]

Film

In 2018 Nadler co-financed and served as executive producer on Motherless Brooklyn, a crime drama film. Norton also stars in the film, along with Willem Dafoe, Bruce Willis, and Alec Baldwin. The film premiered at the 2019 Telluride Film Festival, as well as the 2019 Toronto International Film Festival, and was selected as the closing film of the 2019 New York Film Festival.[15][16][17]

In 2019, Nadler co-financed and served as producer on the drama Palmer, starring Justin Timberlake, which was released in 2021.[18] Palmer became the "Most-Watched Weekend’ Ever" on AppleTV+.[19]

References

  1. ^ a b c d e "Can Kensho Bring Google Style Search To Stock Picking?". Forbes. May 7, 2014. Retrieved 2016-04-02.
  2. ^ Donnelly, Timothy. "The Doors of Perception". Boston Review. ISSN 0734-2306. Retrieved 2016-03-19.
  3. ^ Popper, Nathaniel (2016-02-25). "The Robots Are Coming for Wall Street". The New York Times. ISSN 0362-4331. Retrieved 2016-03-19.
  4. ^ "Daniel Nadler". IMDb. Retrieved 2019-08-10.
  5. ^ a b c d CNBC Television (2025-02-19). Meet OpenEvidence, the 'ChatGPT' for verified doctors. Retrieved 2025-05-10 – via YouTube.
  6. ^ a b Rooney, Kate (2025-02-19). "AI health-care startup OpenEvidence raises funding from Sequoia at $1 billion valuation". CNBC. Retrieved 2025-05-10.
  7. ^ a b Haupt, Angela (2025-05-08). "TIME100 Health: Daniel Nadler". TIME. Retrieved 2025-05-10.
  8. ^ a b Gara, Antoine. "Wall Street Tech Spree: With Kensho Acquisition S&P Global Makes Largest A.I. Deal In History". Forbes. Retrieved 2018-05-18.
  9. ^ "Technology Pioneers 2016 - World Economic Forum". widgets.weforum.org. Retrieved 2018-10-07.
  10. ^ "OpenEvidence". OpenEvidence. Retrieved 2025-05-27.
  11. ^ Dorn, Spencer (2024-12-13). "How AI Is Changing The Way Doctors Access Medical Knowledge". Forbes. Retrieved 2024-12-13.
  12. ^ Macmillan. "Lacunae | Daniel Nadler | Macmillan". Macmillan. Retrieved 2016-03-19.
  13. ^ "NPR's Book Concierge". NPR.org. Retrieved 2017-01-17.
  14. ^ "Academy of American Poets, Board of Directors". Academy of American Poets. 2014-01-20. Retrieved 2018-08-30.
  15. ^ Edward Norton’s ‘Motherless Brooklyn’ to Close New York Film Festival
  16. ^ Lang, Brent (July 23, 2019). "Toronto Film Festival: 'Joker,' 'Ford v Ferrari,' 'Hustlers' Among Big Premieres". Variety. Retrieved July 23, 2019.
  17. ^ Warner Bros. Dates ‘Dune’ For November 2020 & More
  18. ^ "Justin Timberlake to Star in Homecoming Drama 'Palmer'". The Hollywood Reporter. 5 September 2019. Retrieved 2019-10-26.
  19. ^ Donnelly, Matt (2021-02-01). "Apple TV Plus Touts 'Most-Watched Weekend' Ever With Premiere of Justin Timberlake's 'Palmer'". Variety. Retrieved 2023-11-03.


This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.